# Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch

Study · id `cardio:ct-nct06331507` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT06331507](<https://clinicaltrials.gov/study/NCT06331507>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT06331507

Browse, organ or system: Heart  
Browse, condition area: Heart failure  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 292 participants.

## Technical summary

Registry record NCT06331507. Allocation not applicable; no masking; primary purpose diagnostic. Start 2021-09-02 (actual); primary completion 2023-06-29 (actual). Results posted on 2024-07-17.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose diagnostic
- Phase: Not applicable
- Enrolled: 292 participants (enrolled count; ClinicalTrials.gov record NCT06331507, source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)
- Started: 2021-09-02 (actual) (ClinicalTrials.gov record NCT06331507, source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)
- Primary completion: 2023-06-29 (actual) (ClinicalTrials.gov record NCT06331507, source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)
- Completion: 2023-06-29 (actual) (ClinicalTrials.gov record NCT06331507, source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)
- Results first posted: 2024-07-17 (ClinicalTrials.gov record NCT06331507, source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT06331507, source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "TERMINATED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct06331507-2024-07-17`, retrieved 2026-10-31)

## The registry's words

- Brief title: Refinement and Assessment of New MRI Technologies for Cardiovascular Exams Using the Phillips CMR Patch
- Condition: Cardiomyopathies
- Intervention (Device): CMR patch
- Lead sponsor: University of Michigan
- Lead sponsor class: OTHER
- Collaborator: Philips Health Care
- Collaborator class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Cardiomyopathy (heart muscle disease) (`cardio:cardiomyopathy`)
- Registry lists this organization as the lead sponsor: University of Michigan (`cardio:org-university-of-michigan`)

## Provenance

Content hash: 74d71ee2b9edac3df5fa74e8b94c9f1c1313f2abc4bf1883e971b28460d6d159
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
